If you are planning to invest in biotechnology (biotech) companies, you should be aware of two general characteristics, writes Dr Mike Tubbs.
Please be aware that the Capital & Conflict website is no longer being updated.
But, if you’re ready to take back control of your money and get intelligent insight, in plain English, about the threats to your money and how to avoid them – then look no further.
Get access to our free bulletin Fortune & Freedom – your 100% FREE daily insight into the truth about your money – behind the headlines, jargon and spin.
Sign up today for FREE, and start getting my market insights delivered to your inbox every day…
GET FREE ACCESS NOW!If you are planning to invest in biotechnology (biotech) companies, you should be aware of two general characteristics, writes Dr Mike Tubbs.
From time to time we may tell you about regulated products issued by Southbank Investment Research Limited. With these products your capital is at risk. You can lose some or all of your investment, so never risk more than you can afford to lose. Seek independent advice if you are unsure of the suitability of any investment. Southbank Investment Research Limited is authorised and regulated by the Financial Conduct Authority. FCA No 706697. https://register.fca.org.uk/.
© 2021 Southbank Investment Research Ltd. Registered in England and Wales No 9539630. VAT No GB629 7287 94.
Registered Office: 2nd Floor, Crowne House, 56-58 Southwark Street, London, SE1 1UN.
Terms and conditions | Privacy Policy | Cookie Policy | FAQ | Contact Us | Top ↑